title: ST segment tracking for rapid determination of patency of the infarct-related artery in acute myocardial infarction.
abstract: OBJECTIVE
  This study was designed to test the hypothesis that monitoring the ST segment on a single electrocardiographic (ECG) lead reflecting activity in the infarct zone provides sensitive and specific recognition of reperfusion within 60 min of initiation of therapy in acute myocardial infarction.
  
  
  BACKGROUND
  Infarct-related arteries that fail to recanalize early may benefit from immediate rescue angioplasty. Hence, detection of reperfusion has important practical clinical implications.
  
  
  METHODS
  Of 41 patients with acute myocardial infarction who had ambulatory ECG (Holter) monitors placed, 38 had adequate ST segment monitoring for 3 h; 35 of the 38 were treated with thrombolytic agents and 3 with primary angioplasty. All patients underwent early coronary angiography and were classified into two groups: Group P (22 patients) had angiographic patency (Thrombolysis in Myocardial Infarction [TIMI] grade 2 or 3 flow), the Group O (16 patients) had persistent occlusion (TIMI grade 0 or 1 flow) of the infarct-related vessel at 60 min from initiation of therapy. The initial ST segment level was defined as the first ST segment level recorded; the peak ST segment level was defined as the highest ST segment level measured during the 1st 60 min. To assess the optimal ST segment recovery criteria for reperfusion, the presence or absence of a > or = 75%, > or = 50% and > or = 25% decrement from initial and peak ST segment levels, sampled and analyzed at 2.5-, 5-, 10-, 15-and 20-min intervals, was correlated with patency of the infarct-related artery at 60 min.
  
  
  RESULTS
  ST segment recovery of > or = 50% reduction from peak ST segment levels with sampling rates at < or = 10-min intervals provided the optimal criterion for recognizing coronary artery patency at 60 min (sensitivity 96%, 95% confidence interval [CI] 77% to 99%; specificity 94%, 95% CI 69% to 99%, p < 0.0001). The subgroup of 13 patients in Group P with TIMI grade 3 reperfusion flow all met this criterion (sensitivity 100%, 95% CI 75% to 100%). The use of the initial ST segment level as the baseline for determining the presence of a > or = 50% reduction in ST segment levels within 60 min was less sensitive. Prediction of coronary reperfusion within 60 min of therapy on the basis of a > or = 75% decrement from peak ST segment levels was less sensitive, and the use of a > or = 25% decrement was less specific.
  
  
  CONCLUSIONS
  ST segment monitoring of a single lead reflecting the infarct zone provides a reliable method for assessing reperfusion within 60 min of acute myocardial infarction. Optimal criteria for ECG reperfusion include a > or = 50% decrease from peak ST segment levels, with ST segment measurements recorded continuously or at least every 10 min.
authors.affiliation: Department of Medicine, University of Miami School of Medicine, Florida, USA.
authors.forename: A R
authors.initials: AR
authors.lastname: Fernandez
authors.forename: R F
authors.initials: RF
authors.lastname: Sequeira
authors.forename: S
authors.initials: S
authors.lastname: Chakko
authors.forename: L F
authors.initials: LF
authors.lastname: Correa
authors.forename: E J
authors.initials: EJ
authors.lastname: de Marchena
authors.forename: R A
authors.initials: RA
authors.lastname: Chahine
authors.forename: D A
authors.initials: DA
authors.lastname: Franceour
authors.forename: R J
authors.initials: RJ
authors.lastname: Myerburg
mesh_terms: D016255:Anistreplase / Q000008:administration & dosage; D006328:Cardiac Catheterization; D016001:Confidence Intervals; D017023:Coronary Angiography; D003327:Coronary Disease / Q000175:diagnosis* / Q000188:drug therapy; D004359:Drug Therapy, Combination; D015716:Electrocardiography, Ambulatory / Q000187:drug effects / Q000295:instrumentation / Q000379:methods* / Q000706:statistics & numerical data; D006801:Humans; D008790:Metoprolol / Q000008:administration & dosage; D009203:Myocardial Infarction / Q000175:diagnosis* / Q000188:drug therapy; D015588:Observer Variation; D011446:Prospective Studies; D012680:Sensitivity and Specificity; D015912:Thrombolytic Therapy / Q000379:methods / Q000706:statistics & numerical data; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage; D014654:Vascular Patency
chemical_list: D016255:Anistreplase; D010959:Tissue Plasminogen Activator; D008790:Metoprolol